Hochdorf and Pharmalys are proud to announce the official launch of a new, jointly owned company, Hochdorf Laboratories SA. This joint venture (JV), led by Hochdorf, is a supported by its owner, AS Equity Partners.

The JV combines Hochdorf’s production technology and manufacturing expertise with Pharmalys’ brand portfolio and global market access. By integrating defined activities, including infant nutrition brands, intellectual property and technical know-how, into one legal entity, the partnership will drive increased efficiency, faster decision-making and sustainable profitable growth, the entities say.

“The formation of this joint venture represents a decisive step forward in our vision for Hochdorf. AS Equity Partners remains committed to providing the strategic and financial backing necessary to ensure this venture delivers long-term value for all stakeholders,” said Andreas Schulte, founder and managing partner at AS Equity Partners. “By bridging Hochdorf’s industrial excellence with Pharmalys’ commercial strength, we are creating a high-performance platform poised for international expansion,” said Amir Mechria, chairman of the board at Pharmalys Laboratories.